WST Stock

EXTON, Pa., Jan. 30, 2025 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST), a leading company in innovative solutions for injectable drug delivery, has announced that it will share its financial results for the fourth quarter and the entire year of 2024 before the market opens on Thursday, February 13, 2025. Following this, there will be a conference call at 9:00 a.m. Eastern Time to discuss the results and future business outlook.

EXTON, Pa., Jan. 28, 2025 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST), a leading company in innovative solutions for injectable drug delivery, has announced that its Board of Directors has approved a dividend of $0.21 per share for the first quarter of 2025. This dividend will be distributed on February 11, 2025, to shareholders who are on record as of February 7, 2025.

EXTON, Pa., Jan. 22, 2025 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST), a worldwide leader in solutions for injectable drug delivery, has announced the launch of Daikyo PLASCAP® Ready-to-Use Validated (RUV) closures in a new nested format with various configurations at the Pharmapack event in Paris, France. This new product supports the growing demand for advanced therapies, particularly in the rapidly evolving field of cell and gene therapy treatments.

WST is still growing strong, especially in the Pharma market sector. However, the drop in its Generics and Biologics divisions is worrying.

EXTON, Pa., Jan. 6, 2025 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST), a leading company in innovative solutions for injectable drug delivery, has announced that Cindy Reiss-Clark, Sr. VP and Chief Commercial Officer; Chad Winters, VP of Finance and Chief Accounting Officer; and John Sweeney, VP of Investor Relations, will speak at the CJS 25th Annual "New Ideas for the New Year" Virtual Investor Conference on January 14, 2025, at 10:15 a.m. ET. A live audio webcast will be accessible in the Investors section of their website, www.westpharma.com.

Investors who focus on Medical - Dental Supplies stocks probably know about Labcorp (LH) and West Pharmaceutical Services (WST). However, which of these companies is the better choice for those seeking undervalued stocks?

WST is still growing strong, especially in the Pharma market sector. However, the drop in its Generics and Biologics divisions is worrying.

EXTON, Pa., Dec. 11, 2024 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST), a worldwide leader in creative solutions for injectable drug delivery, has announced that its Board of Directors has chosen Janet Haugen as its latest member. With her addition, Ms.

West Pharmaceutical Services, Inc. (NYSE: WST), a leading company in injectable drug solutions, has announced its participation in several upcoming conferences. They will present at the UBS Global Healthcare Conference in California on November 12, 2024, the Jefferies Healthcare Conference in London on November 19, 2024, and the Stephens Annual Investment Conference in Nashville on November 21, 2024. A live audio webcast of these presentations will be accessible on the company's website, with replays available for about 90 days after the events.